國新健康(000503.SZ)就取消2016年度定增事項 收到終止審查通知書
格隆匯11月18日丨國新健康(000503.SZ)公佈,公司於2019年9月29日召開了第十屆董事會第十二次會議、於2019年10月16日召開了2019年第二次臨時股東大會,審議通過了《關於取消公司2016年度非公開發行股票事項的議案》。綜合考慮資本市場變化、融資環境、公司業務發展規劃等各方面因素,公司對再融資規劃進行調整,取消2016年度非公開發行股票事項,並向中國證監會申請撤回相關申請文件,未來根據公司及市場情況擇機推出適合公司需要的再融資方案。
公司於近日收到《中國證監會行政許可申請終止審查通知書》([2019]335號),中國證監會根據《行政許可法》及《中國證券監督管理委員會行政許可實施程序規定》第二十條的規定,決定終止對公司行政許可申請的審查。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.